HYLENEX Recombinant is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Halozyme, Inc.. The primary component is Hyaluronidase (human Recombinant).
Product ID | 18657-117_308df247-a446-4284-8a1a-04410cd25e52 |
NDC | 18657-117 |
Product Type | Human Prescription Drug |
Proprietary Name | HYLENEX Recombinant |
Generic Name | Hyaluronidase (human Recombinant) |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2005-12-02 |
Marketing Category | NDA / NDA |
Application Number | NDA021859 |
Labeler Name | Halozyme, Inc. |
Substance Name | HYALURONIDASE (HUMAN RECOMBINANT) |
Active Ingredient Strength | 150 [USP'U]/mL |
Pharm Classes | Endoglycosidase [EPC],Glycoside Hydrolases [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2005-12-02 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021859 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2005-12-02 |
Marketing Category | NDA |
Application Number | NDA021859 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2005-12-02 |
Marketing Category | NDA |
Application Number | NDA021859 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2005-12-02 |
Marketing End Date | 2016-02-09 |
Marketing Category | NDA |
Application Number | NDA021859 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2005-12-02 |
Ingredient | Strength |
---|---|
HYALURONIDASE (HUMAN RECOMBINANT) | 150 [USP'U]/mL |
SPL SET ID: | 3023cc56-ed4b-4e87-b3a1-81b20943f658 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
18657-117 | HYLENEX Recombinant | Hyaluronidase (Human Recombinant) |
50090-4534 | HYLENEX Recombinant | Hyaluronidase (Human Recombinant) |